Volume 68 Received 13 February 2012 | ||||||||||
| ||||||||||
aDepartment of Physics, C. Abdul Hakeem College of Engineering & Technology, Melvisharam, Vellore 632 509, India,bDepartment of Physics, Thanthai Periyar Government Institute of Technology, Vellore 632 002, India, and cDepartment of Organic Chemistry, University of Madras, Maraimalai Campus, Chennai 600 025, India
Correspondence e-mail: smurugavel27@gmail.com
In the title compound, C14H9O2S, the benzothiazole unit is oriented at a dihedral angle of 7.1 (1)° with respect to the benzodioxole unit. The dioxole ring adopts flattened envelope conformation with the methylene C atom at the flap. The crystal packing is stabilized by
-
interactions [centroid-centroid distances = 3.705 (1) and 3.752 (1) Å], C-H
interactions and a short S
S contact of 3.485 (1) Å.
For background to the applications of benzothiazoles in the chemical industry, see: Bradshaw et al. (2002
); Delmas et al. (2002
); Hutchinson et al. (2002
). For the pharmacological activity of benzothiazole derivatives, see: Repic et al. (2001
); Schwartz et al. (1992
). For ring puckering analysis, see: Cremer & Pople (1975
). For related structures, see: Baryala et al. (2010
); Zhang et al. (2008
).
|
|
| ||||||||||||||||||||||
Data collection: APEX2 (Bruker, 2004
); cell refinement: APEX2 and SAINT (Bruker, 2004
); data reduction: SAINT and XPREP (Bruker, 2004
); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
); molecular graphics: ORTEP-3 (Farrugia, 1997
); software used to prepare material for publication: SHELXL97 and PLATON (Spek, 2009
).
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: GK2459 ).
The authors thank Dr Babu Vargheese, SAIF, IIT, Madras, India, for his help with the data collection.
Baryala, Y., Zerzouf, A., Salem, M., Essassi, E. M. & El Ammari, L. (2010). Acta Cryst. E66, o857.
![[details]](../../../../../../e/graphics/details.gif)
Bradshaw, T. D., Chua, M. S., Browne, H. L., Trapani, V., Sausville, E. A. & Stevens, M. F. G. (2002). Br. J. Cancer, 86, 1348-1354.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Bruker (2004). APEX2, SAINT and XPREP. Bruker AXS Inc., Madison, Wisconsin, USA.
Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc. 97, 1354-1358.
![[ISI]](../../../../../../logos/isiborder.gif)
Delmas, F., Di Giorgio, C., Robin, M., Azas, N., Gasquet, M., Detang, C., Costa, M., Timon-David, P. & Galy, J.-P. (2002). Antimicrob. Agents Chemother. 46, 2588-2594.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.
![[details]](../../../../../../j/graphics/details.gif)
Hutchinson, I., Jennings, S. A., Vishnuvajjala, B. R., Westwell, A. D. & Stevens, M. F. G. (2002). J. Med. Chem. 45, 744-747.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Repic, O., Prasad, K. & Lee, G. T. (2001). Org. Process Res. Dev. 5, 519-527.
Schwartz, A., Madan, P. B., Mohacsi, E., O-Brien, J. P., Todaro, L. J. & Coffen, D. L. (1992). J. Org. Chem. 57, 851-856.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Sheldrick, G. M. (1996). SADABS. University of Göttingen, Germany.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Spek, A. L. (2009). Acta Cryst. D65, 148-155.
![[details]](../../../../../../d/graphics/details.gif)
Zhang, Y., Su, Z.-H., Wang, Q.-Z. & Teng, L. (2008). Acta Cryst. E64, o2065.
![[details]](../../../../../../e/graphics/details.gif)